Navigation Links
Mayo Clinic develops new way to rate severity of colitis, a common cause of diarrhea
Date:10/31/2011

ROCHESTER, Minn. -- Mayo Clinic researchers have developed a new way to assess a common cause of chronic diarrhea, microscopic colitis, using the Microscopic Colitis Disease Activity Index. A study describing the index was released today during the American College of Gastroenterology 2011 Annual Scientific Meeting and Postgraduate Course in Washington. The index provides a consistent way to assess the condition's severity.

"Until now, physicians have not had a way to objectively and consistently score the severity of a patient's disease beyond simply counting the number of bowel movements per day," says author Darrell Pardi, M.D., a Mayo Clinic gastroenterologist. The assessment also accounts for symptoms other than diarrhea, such as abdominal pain, urgency, and incontinence.

"This assessment is a significant step forward, as it correlates a patient's symptoms with the physicians' understanding of the severity of microscopic colitis," Dr. Pardi says. Using the assessment index in future studies, researchers will more easily compare treatments for this condition.

Microscopic colitis is recognized as a common cause of chronic diarrhea, causing perhaps 30 percent of all cases of the condition in older patients. Microscopic colitis is a chronic, inflammatory condition of the large intestine (colon) that causes watery diarrhea and, sometimes, abdominal pain. The disorder gets its name from the microscopic examination of tissue required to identify it.


'/>"/>

Contact: Brian Kilen
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1

Related medicine news :

1. Mayo Clinic: Short training course significantly improves detection of precancerous polyps
2. Consortium gets $7.2 million contract renewal to promote phase II clinical trials
3. New oncolytic virus shows improved effectiveness in preclinical testing
4. Clinical trial shows first evidence that anal cancer is preventable
5. UCSF-Pfizer partnership yields projects aimed at clinical trials
6. For Those With Mystery Illnesses, a Clinic of Last Resort
7. Mayo Clinic detective work shows possible side effect in macular degeneration drug
8. Mayo Clinic study: PSA test valuable in predicting biopsy need, low-risk prostate cancer
9. Mayo Clinic study guides physicians using therapeutic cooling to treat cardiac arrest patients
10. Timing for clinical trials for stem cell therapy in spinal cord injuries is right
11. Mayo Clinic wins grant to study ethics of sharing genetic test results with relatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology: